Masaki Hayakawa Selected Research

Masaki Hayakawa Research Topics

Disease

7	Thrombotic Thrombocytopenic Purpura 01/2022 - 01/2012
6	Thrombosis (Thrombus) 04/2021 - 09/2012
5	Hemorrhage 11/2021 - 10/2016
4	acquired Thrombotic thrombocytopenic purpura 04/2021 - 03/2016
2	COVID-19 01/2022 - 04/2021
2	Macular Degeneration (Age-Related Maculopathy) 10/2021 - 01/2018
2	Thrombocytopenia (Thrombopenia) 04/2021 - 03/2016
2	Disseminated Intravascular Coagulation 04/2021 - 04/2021
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 10/2016
2	Glucose Intolerance 02/2018 - 01/2018
2	Thrombotic Microangiopathies 09/2016 - 01/2012
1	Evans Syndrome 01/2022
1	Broca Aphasia (Expressive Aphasia) 01/2022
1	Essential Thrombocythemia 01/2022
1	Bradycardia 10/2021
1	Sudden Death 10/2021
1	Hypotension (Low Blood Pressure) 10/2021
1	Wounds and Injuries (Trauma) 06/2021
1	Hemolysis 06/2021
1	Thromboembolism 04/2021
1	Pneumonia (Pneumonitis) 04/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Factor V Deficiency 01/2020
1	Femoral Fractures (Femoral Fracture) 01/2020
1	Infections 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Multiple Myeloma 01/2020
1	Neoplasms (Cancer) 01/2020
1	Paraproteinemias (Monoclonal Gammopathy) 01/2020
1	Wound Infection (Wound Infections) 01/2020
1	Reperfusion Injury 11/2019
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 07/2019
1	Inflammation (Inflammations) 07/2019
1	Body Weight (Weight, Body) 02/2018
1	Hyperphagia (Overeating) 01/2018
1	Hyperglycemia 01/2018
1	Abdominal Obesity 01/2018
1	Obesity 01/2018
1	Angiodysplasia 09/2017
1	HELLP Syndrome 09/2017
1	Disease Progression 01/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Protein S Deficiency (Deficiency, Protein S) 09/2016
1	Pulmonary Embolism 09/2016
1	Human Influenza (Influenza) 09/2016
1	Rupture 03/2016
1	Abdominal Aortic Aneurysm 03/2016
1	Aneurysm (Aneurysms) 03/2016
1	Brain Diseases (Brain Disorder) 04/2015

Drug/Important Bio-Agent (IBA)

11	von Willebrand FactorIBA 01/2022 - 12/2013
8	thiamine triphosphorate (TTP)IBA 10/2021 - 01/2012
5	AutoantibodiesIBA 12/2020 - 03/2016
4	SteroidsIBA 01/2022 - 04/2015
3	AntigensIBA 04/2021 - 10/2016
2	AntibodiesIBA 11/2021 - 10/2003
2	Metalloproteases (Metalloproteinases)IBA 11/2021 - 09/2016
2	ThrombospondinsIBA 11/2021 - 09/2016
2	DisintegrinsIBA 11/2021 - 09/2016
2	AnticoagulantsIBA 04/2021 - 01/2020
2	Dacarbazine (DIC)FDA LinkGeneric 04/2021 - 04/2021
2	Rituximab (Mabthera)FDA Link 12/2020 - 01/2017
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2019 - 04/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2018 - 01/2018
2	psicose (D-psicose)IBA 02/2018 - 01/2018
1	VaccinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	antineoplaston A10 (A 10)IBA 11/2021
1	formycin diphosphate (FDP)IBA 04/2021
1	Heparin (Liquaemin)FDA LinkGeneric 04/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Factor V (Coagulation Factor V)IBA 01/2020
1	ParaproteinsIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	afliberceptIBA 01/2018
1	Capsules (Microcapsules)IBA 09/2017
1	GlucocorticoidsIBA 04/2017
1	Biological ProductsIBA 04/2017
1	Immunoglobulins (Immunoglobulin)IBA 04/2017
1	Protein SIBA 09/2016
1	CytokinesIBA 09/2016
1	Blood Substitutes (Artificial Blood)IBA 03/2016
1	Shiga Toxin (Shigella Toxin)IBA 04/2015
1	ThrombomodulinIBA 04/2015

Therapy/Procedure

5	Plasma Exchange 10/2021 - 04/2015
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2022 - 03/2016
2	Heart-Assist Devices 06/2021 - 01/2020
2	Therapeutics 04/2021 - 01/2017
1	Plasmapheresis 01/2022
1	Extracorporeal Membrane Oxygenation 04/2021
1	Off-Label Use 12/2020
1	Debridement 01/2020
1	Renal Dialysis (Hemodialysis) 01/2020
1	Replacement Arthroplasty 01/2020
1	Hepatectomy 11/2019
1	Intravitreal Injections 01/2018
1	Central Venous Catheters 09/2016
1	Perioperative Period 03/2016
1	Blood Vessel Prosthesis Implantation 03/2016
1	Hemodiafiltration 04/2015